SCHEMBL22624909

SCHEMBL22624909

C=CC(=O)OCC(C)(COc1ccc2cc(-c3ccc(OC)cc3OC(F)(F)F)c(=O)oc2c1)CC(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAOB P27338 8/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 2/20 0.37
GAA P10253 2/20 0.37
HPGD P15428 2/20 0.37
CA12 O43570 1/20 0.37
CA2 P00918 1/20 0.37
GLA P06280 1/20 0.37
CA3 P07451 1/20 0.37
CA4 P22748 1/20 0.37
CA6 P23280 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
SLC16A3 O15427 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25848198 0.91 NPC1 (0.43) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL25848241 0.90 NPC1 (0.42) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL22624933 0.89 NPC1 (0.43) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL22625169 0.89 NPC1 (0.42) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL22625299 0.89 NPC1 (0.42) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL22624934 0.89 NPC1 (0.42) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL22625202 0.88 NPC1 (0.42) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL22625141 0.88 THRB (0.37) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL22625464 0.88 NPC1 (0.41) NPC1RAB9AMEN1KMT2AMAOB
SCHEMBL22625013 0.87 NPC1 (0.40) NPC1RAB9AMEN1KMT2AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed
EP-3583102-B1 HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2020-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 NPC1 1051/4885RAB9A 1916/4885MEN1 3033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.